Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
SIRT Therapy for Neuroendocrine Tumours Webi-Natter Event – May 30th
- Neuroendocrine Cancer UK is thrilled to announce an upcoming Webi-Natter event focused on the recent news of NICE's approval of SIRT Therapy for neuroendocrine tumours. Scheduled for May 30th from 6:00pm to 7:30pm (GMT), this event will delve into the implications...
Launch of Rareminds Wellbeing Hub and Rare Minds Matter Survey Results
- Launch of Rareminds Wellbeing Hub and Release of "Rare Minds Matter - Rare Disease and Mental Health 2023 Survey Results" We are thrilled to announce the launch of the Rareminds Wellbeing Hub, a vital resource designed to help individuals navigate some of the more...
NICE Recommends SIRT Therapy for neuroendocrine tumours
We are delighted to share with you the news that NICE has recommended SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour-related liver metastases. NICE Interventional procedures guidance [IPG786]: Selective internal radiation...